THOR Market Cap History Table | ||||||||||||
Also see: THOR Shares Outstanding History and THOR YTD Return |
THOR Market Cap History Table | ||||||||||||
Also see: THOR Shares Outstanding History and THOR YTD Return |
THOR Market Cap History Chart | |||||||||||||||
+31.83% CAGR Mouse over chart for data details
|
THOR Stock Price Chart |
About Synthorx Inc |
Synthorxis is a biopharmaceutical company. Co.'s platform technology expands the genetic code by adding a DNA base pair and is designed to create optimized biologics, which it refers to as Synthorins. Co.'s main product candidate, THOR-707, is a variant of innate lymphoid (IL)-2 designed to kill tumor cells by increasing CD8+ T and natural killer cells without causing vascular leak syndrome observed with approved recombinant IL-2 (aldesleukin). Co.'s second IL-2 program is focused on autoimmune disorders based on the observation that low doses of IL-2 can dampen immune cell activation through selective proliferation of CD4+ regulatory T cells. Co. is developing an IL-2 autoimmune Synthorin. We show 5 historical shares outstanding datapoints in our THOR shares outstanding history coverage, used to compute THOR market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing THOR market cap history over the course of time is important for investors interested in comparing THOR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of THOR versus a peer is one thing; comparing THOR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like THOR can fluctuate over the course of history. With this page we aim to empower investors researching THOR by allowing them to research the THOR market cap history. |
THOR Current Stock Quote |
Free THOR Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
THOR Share Performance |
Market Cap Peers |
Synthorx (THOR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
THRD Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.